Phase 2

MMF & Voclosporin

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT05306873

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Mycophenolate Mofetil

Placebo for Mycophenolate Mofetil

Voclosporin

Placebo for Voclosporin

Mycophenolate Mofetil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-16. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2024-09-19.